Currency
Get Your BitCoins at COINBASE
Tuesday, September 20, 2016
GlaxoSmithKline Names Emma Walmsley as Chief Executive Officer Designate
GlaxoSmithKline has named Emma Walmsley as chief executive officer designate to take over from Andrew Witty when he retires next year.
from WSJ.com: US Business http://ift.tt/2d7vk03
via
IFTTT
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment